Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.

作者: Yeny Castillero-Trejo , Susan Eliazer , Lilin Xiang , James A. Richardson , Robert L. Ilaria

DOI: 10.1158/0008-5472.CAN-05-1704

关键词:

摘要: Ewing sarcoma is the second most common malignant pediatric bone tumor. Over 80% of contain oncogene EWS/FLI-1, which encodes EWS/FLI-1 oncoprotein, a hybrid transcription factor comprised NH2-terminal sequences from RNA-binding protein EWS and DNA-binding COOH-terminal regions Ets FLI-1. Although numerous genes are dysregulated by advances in cancer biology have been hindered lack an animal model because EWS/FLI-1-mediated cytotoxicity. In this study, we developed conditions for isolation propagation murine primary bone-derived cells (mPBDC) that stably express EWS/FLI-1. Early-passage mPBDCs were immortalized culture but inefficient at tumor induction, whereas later-passage formed sarcomatous tumors immunocompetent syngeneic mice. Murine contained morphologically primitive lacked definitive lineage markers. Molecular characterization revealed some not all had acquired novel, clonal in-frame p53 mutation associated with constitutive loss p21 expression. Despite indications secondary events facilitated mPBDC tumorigenesis, remained highly dependent on efficient transformation clonogenic assays. This will be useful tool dissecting molecular pathogenesis provides rationale broader use organ-specific progenitor cell populations study human sarcoma.

参考文章(50)
Angelo P Dei Tos, Andrew L Folpe, John R Goldblum, Bahig M Shehata, Brian P Rubin, Sharon W Weiss, Wendy Liu, Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. The American Journal of Surgical Pathology. ,vol. 29, pp. 1025- 1033 ,(2005) , 10.1097/01.PAS.0000167056.13614.62
Andrei Maksimenko, Claude Malvy, Gregory Lambert, Jean‐Rémy Bertrand, Elias Fattal, Jean Maccario, Patrick Couvreur, Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies. Pharmaceutical Research. ,vol. 20, pp. 1565- 1567 ,(2003) , 10.1023/A:1026122914852
M Dworzak, H Gadner, S Strehl, I M Ambros, H Kovar, E Schnell, P F Ambros, Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene. ,vol. 5, pp. 1067- 1070 ,(1990)
Batia Stark, Batia Stark, Celia Mor, Marta Jeison, Rima Gobuzov, Ian J. Cohen, Yaacov Goshen, Jerry Stein, Salvi Fisher, Shifra Ash, Itzhak Yaniv, Rina Zaizov, Rina Zaizov, Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors. Journal of Neuro-oncology. ,vol. 31, pp. 3- 8 ,(1997) , 10.1023/A:1005731009962
John R. Goldblum, Sharon W. Weiss, Enzinger and Weiss's Soft Tissue Tumors ,(2001)
Robert L Ilaria Jr, Robert G Hawley, Richard A Van Etten, None, Dominant Negative Mutants Implicate STAT5 in Myeloid Cell Proliferation and Neutrophil Differentiation Blood. ,vol. 93, pp. 4154- 4166 ,(1999) , 10.1182/BLOOD.V93.12.4154
Enrique C Torchia, Suzanne J Baker, Sobha Jaishankar, Ewing Tumor Fusion Proteins Block the Differentiation of Pluripotent Marrow Stromal Cells Cancer Research. ,vol. 63, pp. 3464- 3468 ,(2003)
Daniel L. Hamilton, Ken Abremski, Site-specific recombination by the bacteriophage P1 lox-Cre system. Cre-mediated synapsis of two lox sites Journal of Molecular Biology. ,vol. 178, pp. 481- 486 ,(1984) , 10.1016/0022-2836(84)90154-2
Maureen Owen, A. J. Friedenstein, Stromal Stem Cells: Marrow‐Derived Osteogenic Precursors Ciba Foundation Symposium. ,vol. 136, pp. 42- 60 ,(1988) , 10.1002/9780470513637.CH4
Katia Scotlandi, Maria Cristina Manara, Piero Picci, Nicola Baldini, Manuela Sarti, Stefania Benini, Daniela Maurici, Massimo Serra, Pier Luigi Lollini, Insulin-like Growth Factor I Receptor-mediated Circuit in Ewing's Sarcoma/Peripheral Neuroectodermal Tumor: A Possible Therapeutic Target Cancer Research. ,vol. 56, pp. 4570- 4574 ,(1996)